CEO Interview at Arctic Securities
Our CEO Dr. Hilja Ibert recently sat down with Pål Falck in Arctic Securities to have a look at Gentian's..
Read more
Diagnostic Efficiency by Gentian - Newsletter H1-2020
Happy New Year 2020 We look forward to exhibiting at and visiting numerous trade shows and congresses..
Read more
CEO interview from DNB North American Life Science Conference
Gentian’s CEO Dr Hilja Ibert was interviewed at DNB North American Life Science Conference in December 2019...
Read more
Meet us in 2020
We will attend several trade shows, conferences and exhibitions in 2020. Here are some of the places you can..
Read more
New article: Calprotectin as a sepsis marker and mortality predictor
“Calprotectin is superior to procalcitonin as a sepsis marker and predictor of 30-day mortality in intensive..
Read more
Product Development Scientist (Temporary)
Temporary position as a Scientist in our Research and Development department
Read more
Gentian News: Turbidimetric Cardiac Immunoassay
Gentian has been granted a funding of 14M NOK distributed over 4 years for our project “Development of a..
Read more
World Antibiotic Awareness Week 2019
Each November, World Antibiotic Awareness Week (WAAW) aims to increase global awareness of antibiotic..
Read more
Cystatin C at ASN Kidney Week 2019
"Cystatin C is indispensable for evaluation of kidney disease"
Read more